Cargando…
Therapy of Primary Liver Cancer
Primary liver cancer (PLC) is a fatal disease that affects millions of lives worldwide. PLC is the leading cause of cancer-related deaths and the incidence rate is predicted to rise in the coming decades. PLC can be categorized into three major histological subtypes: hepatocellular carcinoma (HCC),...
Autores principales: | Feng, Mei, Pan, Yisheng, Kong, Ruirui, Shu, Shaokun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7416132/ https://www.ncbi.nlm.nih.gov/pubmed/32914142 http://dx.doi.org/10.1016/j.xinn.2020.100032 |
Ejemplares similares
-
The breakthrough in primary human hepatocytes in vitro expansion
por: Feng, Mei, et al.
Publicado: (2019) -
Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
por: Feng, Mei, et al.
Publicado: (2023) -
A breakthrough in liver regeneration for treatment of liver cancer
por: Xu, Hao, et al.
Publicado: (2021) -
Advances in postoperative adjuvant therapy for primary liver cancer
por: Zeng, Zhi-Ming, et al.
Publicado: (2022) -
Immune checkpoint therapy in liver cancer
por: Xu, Feng, et al.
Publicado: (2018)